1. Anthrax Treatment Market - Overview
1.1 Definitions and Scope
2. Anthrax Treatment Market - Executive Summary
3. Anthrax Treatment Market - Comparative Analysis
3.1. Company Benchmarking - Key Companies
3.2. Global Financial Analysis - Key Companies
3.3. Market Share Analysis - Key Companies
3.4. Patent Analysis
3.5. Pricing Analysis
4. Anthrax Treatment Market - Start-up Companies Scenario (Premium)
4.1. Key Start-up Company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Venture Capital and Funding Scenario
5. Anthrax Treatment Market – Market Entry Scenario Premium (Premium)
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing Business Index
5.3. Case Studies of Successful Ventures
6. Anthrax Treatment Market - Forces
6.1. Market Drivers
6.2. Market Constraints
6.3. Market Challenges
6.4. Porter's Five Force Model
6.4.1. Bargaining Power of Suppliers
6.4.2. Bargaining Powers of Customers
6.4.3. Threat of New Entrants
6.4.4. Rivalry Among Existing Players
6.4.5. Threat of Substitutes
7. Anthrax Treatment Market – Strategic Analysis
7.1. Value Chain Analysis
7.2. Opportunities Analysis
7.3. Market Life Cycle
8. Anthrax Treatment Market – By Anthrax
8.1. Cutaneous Anthrax
8.1.1. Market Trends by Region
8.1.2. Market Share & Forecast by Region
8.2. Inhalation Anthrax
8.2.1. Market Trends by Region
8.2.2. Market Share & Forecast by Region
8.3. Gastrointestinal Anthrax
8.3.1. Market Trends by Region
8.3.2. Market Share & Forecast by Region
8.4. Injection Anthrax
8.4.1. Market Trends by Region
8.4.2. Market Share & Forecast by Region
9. Anthrax Treatment Market – By Drug Class
9.1. Antibiotics
9.1.1. Market Trends by Region
9.1.2. Market Share & Forecast by Region
9.2. Immunoglobulins
9.2.1. Market Trends by Region
9.2.2. Market Share & Forecast by Region
10. Anthrax Treatment Market – By Distribution Channel (Market Size – $Million/$Billion)
10.1. Hospitals
10.1.1. Market Trends by Region
10.1.2. Market Share & Forecast by Region
10.2. Pharmacies
10.2.1. Market Trends by Region
10.2.2. Market Share & Forecast by Region
10.3. Others Conditions
10.3.1. Market Trends by Region
10.3.2. Market Share & Forecast by Region
11. Anthrax Treatment Market – by Geography (Market Size – $Million/$Billion)
11.1. North America
11.1.1. The U.S.
11.1.2. Canada
11.2. Europe
11.2.1. UK
11.2.2. Germany
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Australia & New Zealand
11.3.6. Rest of Asia-Pacific
11.4. South America
11.4.1. Brazil
11.4.2. Argentina
11.4.3. Chile
11.4.4. Colombia
11.4.5. Rest of South America
11.5. Rest of the World
11.5.1. Middle East
11.5.2. Africa
12. Anthrax Treatment Market – Entropy
13. Anthrax Treatment Market - Industry/Segment Competition Landscape Premium
13.1. Market Share Analysis
13.1.1. Market Share by Product Type – Key Companies
13.1.2. Market Share by Region – Key Companies
13.1.3. Market Share by Country – Key Companies
13.2. Competition Matrix
13.3. Best Practices for Companies
14. Anthrax Treatment Market – Key Company List by Country Premium Premium
15. Anthrax Treatment Market - Company Analysis
15.1. Emergent BioSolutions
15.2. Pfizer Inc.
15.3. GlaxoSmithKline (GSK)
15.4. Bayer AG
15.5. Sanofi
15.6. Merck & Co., Inc.
15.7. Novartis International AG
15.8. Elusys Therapeutics
15.9. PharmAthene, Inc.
15.10. SIGA Technologies
15.11. Cangene Corporation
15.12. DynPort Vaccine Company
15.13. BioThrax
15.14. BioSolutions
15.15. Bavarian Nordic
15.16. Porton Biopharma Limited
15.17. Soligenix, Inc.
15.18. Altimmune, Inc.
15.19. Cleveland BioLabs
15.20. Aradigm Corporation
"Financials to the Private Companies would be provided on best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our
reports include global-level data, niche markets and competitive landscape.